Business
MGC Pharma makes strong debut as London Stock Exchange’s first medicinal cannabis company – Stockhead
MGC Pharma is the first medicinal cannabis company to be admitted to the London Stock Exchange Admission follows successful IPO for $11.6m from sophisticated and…
Link copied toclipboard
- MGC Pharma is the first medicinal cannabis company to be admitted to the London Stock Exchange
- Admission follows successful IPO for $11.6m from sophisticated and institutional investors
- Shares in MGC Pharma rise 60 per cent on LSE trading debut as listing was well received by investors
The share price of medicinal cannabis company MGC Pharmaceuticals (ASX:MXC) soared 60 per cent Tuesday on its first day of trading on the London Stock Exchange (LSE).
MGC Pharma is the first medicinal…
Continue Reading
-
Business23 hours agoWhy this fantastic blue chip ASX 200 share could rise 20%
-
General22 hours agoAlbanese government to freeze construction code until 2029, fast-track housing approvals
-
General16 hours agoPhotographers reveal iconic image of Gough Whitlam and Vincent Lingiari was posed on Wave Hill Walk-Off anniversary
-
Noosa News14 hours agoDog daycare program a TikTok hit for helping disabled find work, friends